IL5 and Increased total eosinophil count: In a successful phase IIa study in the allergen challenge model in mild allergic asthmatics, SB010 significantly attenuated early and late asthmatic bronchoconstriction in association with a decrease in Th2-dependent biomarkers including sputum eosinophilia, sputum tryptase, and plasma IL-5 levels [128].